Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus MR4 Conversion in Stable Liver Transplant
NCT00384202Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2006
- Primary completion
- Nov 2007
- Modality
- RNA-Targeting Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of tacrolimus in Liver transplant rejection, sponsored by Astellas Pharma. Started Oct 2006; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00384202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384202.